CSPG4P1Y: A Potential Drug Target and Biomarker (G114758)

Target Name: CSPG4P1Y

NCBI ID: G114758

CSPG4P1Y

Other Name(s): CSPG4P1 | CSPG4LYP1 | CSPG4LY | CSPG4 pseudogene 1 Y-linked | CSPG4PY1

CSPG4P1Y: A Potential Drug Target and Biomarker

CSPG4P1Y, also known as CSG4-1Y, is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. Its full name is CSPG4-1Y cell surface glycoprotein 4-1Y, and it is a member of the CSPG family of proteins.

The CSPG4P1Y protein is of interest as a potential drug target because it is involved in several important cellular processes in the body, including cell signaling, cell adhesion, and tissue repair. It is also expressed in various diseases, including cancer, neurodegenerative diseases, and gastrointestinal diseases.

One of the key functions of CSPG4P1Y is its role in cell signaling. It is a negative regulator of the protein kinase kinase A3 (PKA), which is involved in many cellular processes, including cell signaling, DNA replication, and stress response. PKA is a widely-expressed protein that is involved in many cellular processes, including cell growth, differentiation, and survival.

CSPG4P1Y is also involved in cell adhesion. It is a critical regulator of tight junctions, which are a type of cell-cell adhesion that helps to maintain the integrity of tissues. tight junctions are involved in many important cellular processes, including the regulation of ion and solute transport, as well as the maintenance of tissue structure and the regulation of cell signaling.

In addition to its role in cell signaling and adhesion, CSPG4P1Y is also involved in tissue repair. It is a regulator of the DNA damage repair pathway, which is involved in the regulation of DNA repair in response to environmental stressors, such as radiation and chemistry substance.

CSPG4P1Y is also of interest as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and gastrointestinal diseases. For example, it is often used as a biomarker for pancreatic cancer, as it is overexpressed in this type of cancer. It is also used as a biomarker for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as it is overexpressed in these conditions.

In conclusion, CSPG4P1Y is a protein that is expressed in various tissues of the body and is involved in several important cellular processes, including cell signaling, cell adhesion, and tissue repair. Its potential as a drug target and biomarker make it an attractive target for future research. Further studies are needed to fully understand the role of CSPG4P1Y in these processes and to develop effective treatments for diseases associated with its dysfunction.

Protein Name: CSPG4 Pseudogene 1 Y-linked

The "CSPG4P1Y Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSPG4P1Y comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets